NSC 655649
Term · Oncology and biomedicine · MLC-T-ONC-005951
A substance that is being studied in the treatment of cancer. It belongs to the families of drugs called antitumor antibiotics and topoisomerase inhibitors. Also called rebeccamycin analog.
| Identifier | MLC-T-ONC-005951 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | rebeccamycin analog |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-005951",
"term": "NSC 655649",
"field": "Oncology and biomedicine",
"definition": "A substance that is being studied in the treatment of cancer. It belongs to the families of drugs called antitumor antibiotics and topoisomerase inhibitors. Also called rebeccamycin analog.",
"synonyms": [
"rebeccamycin analog"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/nsc-655649/"
}
Record 11,986 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.